Heads of research removed from AstraZeneca16th January 2013
AstraZeneca’s new chief executive Pascal Soriot has made changes to the management structure of Britain’s second biggest pharmaceutical company.
Soriot, who took over in October, has removed the heads of research and commercial operations – Martin Mackay and Tony Zook - in a management revamp designed to speed decision-making, with both men leaving the company at the end of January. They will be replaced by three senior research and development roles, while on the commercial side of the company three positions will represent different regions.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Heads of research removed from AstraZeneca
Author: Mark Nicholls
Article Id: 23526
Date Added: 16th Jan 2013